reletrans 15 mikrogram/time depotplastre
orifarm a/s - buprenorphin - depotplastre - 15 mikrogram/time
terbinafin "2care4" 250 mg tabletter
2care4 aps - terbinafinhydrochlorid - tabletter - 250 mg
namuscla
lupin europe gmbh - mexiletine hydrochloride - myotonic lidelser - hjertetapi - namuscla er indiceret til symptomatisk behandling af myotonia i voksne patienter med ikke-dystrofiske myotonic lidelser.
tolosapo 20 mg enterotabletter
2care4 aps - pantoprazolnatriumsesquihydrat - enterotabletter - 20 mg
buprenorphin "2care4" 15 mikrogram/time depotplastre
2care4 aps - buprenorphin - depotplastre - 15 mikrogram/time
melatonin "unimedic pharma" 1 mg/ml oral opløsning
unimedic pharma ab - melatonin - oral opløsning - 1 mg/ml
buprefarm 15 mikrogram/time depotplastre
2care4 aps - buprenorphin - depotplastre - 15 mikrogram/time
duodopa 240+12 mg/ml infusionsvæske, opløsning
abbvie a/s - foscarbidopa, foslevodopa - infusionsvæske, opløsning - 240+12 mg/ml
firdapse (previously zenas)
serb sa - amifampridin - lambert-eaton myasthenic syndrom - andre narkotika stoffer - symptomatisk behandling af lambert-eaton myasthenisk syndrom (lems) hos voksne.
amifampridine serb
serb sa - amifampridine phosphate - lambert-eaton myasthenic syndrome; paraneoplastic syndromes, nervous system; nervous system neoplasms; paraneoplastic syndromes; nervous system diseases; autoimmune diseases of the nervous system; neurodegenerative diseases; neuromuscular diseases; neuromuscular junction diseases; immune system diseases; autoimmune diseases; autoimmune diseases of the nervous system; cancer; neoplasms - andre narkotika stoffer - symptomatisk behandling af lambert-eaton myasthenisk syndrom (lems) hos voksne.